Cameco's share price is down nearly 50% from it's 52-week high, despite what is normally a low beta stock. The Company has a strong balance sheet and over $1 billion in cash. The only issue is earnings. The P/E ratio is very high, but the $74 million in earnings (before adjustments) for 2019 was a paltry 18 cents per share in an oversupplied market for uranium. Cameco management is aware of this, and to quote their own strategy: <blockquote> <h4>We will not produce from our tier-one assets to sell into an oversupplied spot market. During a prolonged period of uncertainty, this could mean leaving our uranium in the ground. As conditions improve, we expect to meet rising demand with production from our best margin operations.</h4>
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.